Vantage Specialty Ingredients FDA Record
- Latest inspection VAI · Jan 23, 2026
- No warning letters matched by name
Vantage Specialty Ingredients has 0 FDA recalls, 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Vantage Specialty Ingredients" is on file.
- Latest inspection
- Jan 23, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 9 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Vantage Specialty Ingredients: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Vantage Specialty Ingredients as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Vantage Specialty Ingredients yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jan 23, 2026 | Fairfield, NJ | Drugs | Voluntary Action Indicated (VAI) | 3016602971 |
| Jun 27, 2023 | Englewood, OH | Drugs | Voluntary Action Indicated (VAI) | 1522195 |
| May 2, 2022 | Linden, NJ | Drugs | Voluntary Action Indicated (VAI) | 2210672 |
| Feb 15, 2018 | Englewood, OH | Veterinary | Voluntary Action Indicated (VAI) | 1522195 |
| Feb 10, 2016 | Linden, NJ | Drugs | No Action Indicated (NAI) | 2210672 |
| Sep 4, 2015 | Englewood, OH | Veterinary | Voluntary Action Indicated (VAI) | 1522195 |
| Aug 20, 2013 | Linden, NJ | Drugs | Voluntary Action Indicated (VAI) | 2210672 |
| Oct 11, 2011 | Linden, NJ | Drugs | Voluntary Action Indicated (VAI) | 2210672 |
| Apr 8, 2010 | Linden, NJ | Drugs | Voluntary Action Indicated (VAI) | 2210672 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3016602971 | Fairfield, NJ | 1 | Jan 23, 2026 |
| FEI 1522195 | Englewood, OH | 3 | Jun 27, 2023 |
| FEI 2210672 | Linden, NJ | 5 | May 2, 2022 |
Vantage Specialty Ingredients and the FDA: common questions
Has Vantage Specialty Ingredients received an FDA warning letter?
No FDA warning letter addressed to the name "Vantage Specialty Ingredients" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Vantage Specialty Ingredients received an FDA Form 483?
FDA has not published a Form 483 for "Vantage Specialty Ingredients" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Vantage Specialty Ingredients?
The most recent FDA inspection on file ended Jan 23, 2026 at Fairfield, NJ and was classified VAI. FDA has 9 inspections of Vantage Specialty Ingredients on file.
Need more than this page shows? Ask about Vantage Specialty Ingredients in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.